Tokyo, Japan

Tooru Kasai

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jeol Ltd.. Active years: 2016.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tooru Kasai

Introduction

Tooru Kasai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of optical microscopy through his innovative designs and patents. His work focuses on enhancing the functionality and usability of optical instruments.

Latest Patents

Tooru Kasai holds a patent for a specimen holder, specimen preparation device, and positioning method. This invention is designed for use with optical microscopes and includes a specimen support that allows the specimen to tilt relative to the optical axis. The adjustment plate features an observation surface for making observations, while the adjustment plate support ensures that the angle between the optical axis and the observation surface is greater than that between the optical axis and the specimen surface. This design improves the accuracy and ease of specimen observation.

Career Highlights

Tooru Kasai is currently employed at Jeol Ltd., a company renowned for its advanced scientific instruments and technologies. His role at Jeol Ltd. allows him to work on cutting-edge projects that push the boundaries of optical microscopy.

Collaborations

Tooru has collaborated with Tsutomu Negishi, a fellow innovator in the field. Their partnership has contributed to the development of advanced technologies in microscopy.

Conclusion

Tooru Kasai's contributions to optical microscopy through his innovative patent demonstrate his commitment to advancing scientific research. His work continues to influence the field and enhance the capabilities of optical instruments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…